Advanced paternal age (APA) is associated with infertility and other reproductive risks. Studies looking at APA and outcomes have used different paternal age cut-offs, which has complicated systematic evaluations of reproductive risk associated with paternal aging. This review of the literature suggests that the impact of paternal aging on adverse reproductive outcomes is small, but significant. Studies suggest the incidence of paternal age effect disorders attributed to de novo autosomal dominant mutations is less than 0.5%. Other risks associated with APA include infertility, miscarriage, birth defects, poor neurodevelopmental outcomes, and childhood cancer.
| INTRODUCTION
Advanced maternal age (AMA) has long been recognized as a risk factor for adverse reproductive outcomes. 1 Reproductive risks include infertility and miscarriage, autosomal aneuploidy, and obstetrical complications such as gestational diabetes, preeclampsia, fetal growth restriction and demise, and preterm delivery. 2 Advanced paternal age (APA) is also associated with increased reproductive risks, but the extent and magnitude of these risks have not been consistently defined.
Currently, there is no consensus for the definition of APA.
Although most professional societies define APA as greater than 40 years of age, the optimal definition remains uncertain. 3 Studies looking at outcomes have used different definitions, which has further complicated the systematic evaluation of reproductive risk associated with paternal age.
In this review, we discuss the mechanisms that contribute to increased reproductive risks associated with APA. We review reproductive outcomes associated with spontaneous conceptions as well as those conceived with assisted reproductive technologies (ART), including in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). We discuss the relationship between APA and de novo autosomal dominant (AD) mutations, termed paternal age effect (PAE) disorders. In addition, we review other adverse reproductive outcomes associated with APA, including congenital malformations, childhood cancer, and neurodevelopmental abnormalities. Finally, we suggest guidelines for the comprehensive genetic counseling and evidence-based management of APA pregnancies and make recommendations for further study.
2 | ADVANCED PATERNAL AGE
| Epidemiologic trends
The trend to delay childbearing has resulted in older maternal and paternal age. As a result of increased life expectancy, increased divorce/remarriage rates and increased access to ART, the age of fathers has increased. 4 According to the National Vital Statistics report, in men younger than 35 years (P < 0.001).
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There are likely multiple factors that contribute to the increased risk of infertility and spontaneous miscarriage associated with paternal age. One explanation is that increasing paternal age negatively affects sperm quality. In a systematic review and meta-analysis of 90 studies, Johnson et al reported that increasing paternal age was associated with decline in semen volume, total sperm count and motility, percentage of morphologically normal sperm, and increased DNA fragmentation rates. 13 Although many of these parameters are not directly correlated with reproductive outcomes, DNA fragmentation has been independently associated with infertility 14 and lower live birth rates. 15 In response to the growing body of evidence on the negative impact of paternal aging on sperm quality, Humm et al suggested that DNA fragmentation should be part of the routine evaluation of sperm quality for APA patients undergoing ART with their partners. 16 
| ART pregnancies
Several studies demonstrated that APA may negatively impact ART outcomes. In mostly retrospective studies, APA was associated with poor embryo quality, 17, 18 reduction of fertilization and implantation rates, 18 and reduction in pregnancy and live birth rates. [17] [18] [19] [20] APA has also been associated with increased miscarriage rates among pregnancies conceived with IVF and ICSI. 21 The mechanisms that lead to poorer ART outcomes are incompletely understood. For APA couples undergoing IVF with ICSI, the negative impact appears to be limited to men with oligospermia. 19 Among oligospermic men, the conception rates decreased 5% for each year of age. 19 The mean age of oligospermic men in this cohort was 36.9 ± 6.3 years. Of note, conception rates were not decreased among APA men with normal sperm counts.
Studies have not consistently demonstrated an association between APA, ART, and miscarriage. 20, 22, 23 The conflicting data may be a result of confounding and inherent bias in the design of these studies. These heterogenous studies are mostly retrospective, included small numbers of older men, and may have unintentionally impacted reproductive outcomes by excluding women with AMA. [23] [24] [25] [26] The potential confounding of maternal age is suggested by the result of animal studies that evaluated maternal DNA repair mechanisms in young, healthy oocytes, which may limit the negative impact of paternal aging. 27, 28 Therefore, studies looking at APA and ART outcomes that excluded AMA patients and/or included young oocyte donors may underestimate the impact of paternal aging.
What is already known about this topic?
• The increasing prevalence of APA has mirrored the rise in maternal age, but there has not been similar attention to the associated risks.
What does this study add?
• In this review, we summarize the reproductive risks associated with APA and suggest guidelines for evidence-based management of these pregnancies.
• Further studies are needed to assess providers' understanding of APA risks and the use of cell free DNA and prenatal whole exome sequencing (WES) to identify de novo paternal age effect (PAE) mutations. The etiology is thought to be related to reduce activity of antioxidant enzymes in seminal plasma and spermatozoa 32 and to a lack of DNA repair mechanisms in spermatozoa. 33, 34 As a result of selfish spermatogonial selection, the cells bearing these de novo mutations are positively selected, leading to progressive clonal expansion. Many of these mutations have gain of function properties, which may have reproductive consequences for genetic variation, disease, and evolution. 35 In 2012, Goriely and Wilkie described a class of syndromes caused by these new dominant heterozygous mutations. 35 These syndromes, termed PAE disorders, present with a triad of features: bias in paternal origin of mutations, strong paternal age effect, and high germline mutation rate. 35 The PAE disorders most strongly associated with APA are caused by mutations in the FGFR2, FGFR3, and RET genes. 36 Point mutations in the FGR2 gene result in increased risk for Apert, Crouzon, and Pfeiffer syndromes. 35 Approximately 97% to 99% of achondroplasia occurs from a de novo mutation in the FGFR3 gene, mostly from the paternal allele. 3, 36 Although the population risk of achondroplasia is 1/15 000, the risk increases to 1/1250 in the 50 to 54 age group as a consequence of these deleterious effects. 3 Mutations in the RET gene can cause multiple endocrine neoplasia, types 2A and 2B. 35 The risk for genetic defects increases linearly for some PAE disorders and exponentially for others. 3, 37, 38 However, the overall risk of de novo AD mutations leading to a clinically significant PAE disorders is low. The best estimate of the incidence of PAE in the offspring of fathers who are 40 years of age or older is less than 0.5%, 39 although
Friedman estimated that the risk was 0.3% to 0.5%, 40 and others have estimated that that risk is lower. 41 Many of these conditions have severe phenotypes, which in our opinion justifies the incorporation of this risk into comprehensive prenatal genetic counseling for APA pregnancies.
| Autosomal aneuploidies
Most studies suggest that the risk of autosomal aneuploidies, including trisomy 21, 18, and 13, do not increase with paternal age. [42] [43] [44] [45] [46] As a result of continual spermatogenesis, the male gamete is less vulnerable to age related nondisjunction aneuploidies. There is biologic plausibility that APA does not increase the risk of aneuploidy, but the conclusion that paternal aging has no effect on aneuploidy is based on the results of small studies that are limited by inherent biases and confounding.
The results of several studies have questioned this conclusion. 52 The odds for having a translocation was observed to double every 10 years after age 25. 
| Copy number variants
All pregnancies are at risk for genomic copy number variants (CNV) regardless of maternal or paternal age. However, some data suggest that the risk of CNV may be increased in the offspring of APA men.
This was suggested in 2011 by Hehir-Kwa et al who studied 118 subjects with intellectual disability and nonrecurrent de novo CNV. 50 They found that 76% of CNVs in this cohort originated in the paternal allele. In contrast, Buzer-Voskamp et al conducted a prospective population-based cohort study in the Netherlands with over 5000 patients that did not find an association between APA and the risk of pathogenic CNV. 55 Further study is needed to determine if APA is associated with increased risk of CNV. 56 In this study, there was strong association between paternal age and the development of cancer, which was especially prevalent among study participants without siblings. Men who were older than 35 years had a 63% higher risk of having offspring who developed these cancers compared with those whose fathers were younger than 25 years.
The mechanism for increased cancer risk is uncertain. One theory has to do with age-related telomere shortening. Telomeres are short, tandem repeats of DNA that cap linear chromosomes. Telomere length shortens with age and can be used as a biomarker for aging.
Whereas telomere shortening has been linked to various diseases, 61 conservation of telomere length is linked to longevity and malignancy.
In the sperm of older men, telomere length is longer. 61 65 Although these odds suggest the magnitude of risk is small, the authors specify that the difference in risk over decades could be substantial. For example, a 40-year-old father would have twice the odds of having a child with diaphragmatic hernia compared with a 20-year-old father given the adjusted OR of 1.04.
| Psychological disease and neurodevelopmental outcomes
In 1958, Johansen reported an association between APA and schizophrenia. 66 Since then, multiple studies have corroborated this finding.
In the Jerusalem Perinatal Study, APA was associated with an increased incidence of offspring with the diagnosis of schizophrenia by age 34 years (RR 2.02, 95% CI, 1.17-3.51 for the 45-49 age group; RR 2.96, 95% CI, 1.6-5.47 for the older than 50 group). 67 In 2011, Lee et al described paternal age related schizophrenia, a variant of schizophrenia characterized by discrepancy between verbal and performance intelligence and earlier age of onset for women at a mean age of 17.2 years. 
| Obstetrical complications
A large, retrospective, American study found no association between paternal age and Apgar scores or birth weight. 72 However, in a population-based retrospective cohort study from 1989 to 2005, female partners of men older than 45 years were more likely to develop pregnancy complications such as hypertensive disorders of pregnancy, placental abruption, intrauterine fetal demise, and preterm delivery. 73 APA, which was defined as older than 45 years in this study, was associated with a 48% increased risk of late stillbirth (adjusted odds ratio 73 The odds were adjusted for several maternal and obstetric characteristics known to be associated with adverse obstetric outcomes.
| Genetic evaluation and management of APA pregnancies
Couples with APA who are considering pregnancy should be offered preconception genetic counseling. Given that there is more awareness of the risks associated with AMA and that maternal and paternal ages are highly correlated, many of these patients may already be presenting for genetic counseling to discuss maternal risks and their pregnancies.
In the preconception visit, the patient and her partner should be counseled about the risks of infertility and miscarriage associated with APA. The relationship between APA and de novo AD mutations should also be addressed. The routine anatomic survey is typically performed between 18 and 22 weeks. 77 Given that the incidence of congenital heart disease among APA conceptions is low, a policy of routine fetal echocardiogram for APA pregnancies is unlikely to significantly impact the detection rate of clinically significant cardiac malformations.
Some AD conditions will have ultrasound findings that may be the Annual Clinical Genetics Meeting (ACMG) practice guidelines, 3 we use age 40 years as the age cut-off for APA in our clinical practice.
Historically, the reproductive risks associated with maternal age have been the focus of prenatal genetic counseling. As we demonstrated in this review, couples with APA should be adequately counseled about the reproductive risks associated with paternal aging.
Overall, the incidence of de novo AD mutations associated with PAE disorders is estimated to be less than 0.5%. These mutations are not evaluated by conventional prenatal diagnostic testing, but may be identified with WES. Prenatal WES is becoming progressively more feasible and could become a recognized and accepted technology in APA pregnancies when prenatal diagnosis is desired. With improvements in noninvasive cell-free DNA in maternal serum screening, further validation studies will also be required to determine the feasibility of screening for paternal age related mutations in targeted genes.
We hope that this review will draw more attention to this important topic. Further studies are needed to assess providers' understanding of APA risks, the use of cell-free DNA as a target for PAE mutations and the role of prenatal WES to evaluate the exome for these de novo point mutations.
